Capricor Therapeutics
CAPR
CAPR
56 hedge funds and large institutions have $32.7M invested in Capricor Therapeutics in 2024 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
51% more funds holding
Funds holding: 37 → 56 (+19)
2.14% more ownership
Funds ownership: 13.21% → 15.35% (+2.1%)
Holders
56
Holding in Top 10
–
Calls
$1.03M
Puts
$377K
Top Buyers
| 1 | +$1.85M | |
| 2 | +$1.36M | |
| 3 | +$1.34M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.13M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$689K |
Top Sellers
| 1 | -$6.09M | |
| 2 | -$633K | |
| 3 | -$217K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$161K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$119K |